Jing‐Ting Chiou

488 total citations
33 papers, 386 citations indexed

About

Jing‐Ting Chiou is a scholar working on Molecular Biology, Epidemiology and Hematology. According to data from OpenAlex, Jing‐Ting Chiou has authored 33 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Epidemiology and 6 papers in Hematology. Recurrent topics in Jing‐Ting Chiou's work include Autophagy in Disease and Therapy (12 papers), Cell death mechanisms and regulation (10 papers) and Acute Myeloid Leukemia Research (5 papers). Jing‐Ting Chiou is often cited by papers focused on Autophagy in Disease and Therapy (12 papers), Cell death mechanisms and regulation (10 papers) and Acute Myeloid Leukemia Research (5 papers). Jing‐Ting Chiou collaborates with scholars based in Taiwan, United Kingdom and United States. Jing‐Ting Chiou's co-authors include Long‐Sen Chang, Yuan‐Chin Lee, Liangjun Wang, Chia‐Hui Huang, Robert Dickinson, Yijun Shi, Jinshyun R. Wu‐Wong, Ying‐Jung Chen, Po‐Wei Huang and Yuying Wu and has published in prestigious journals such as Biochemical Journal, International Journal of Molecular Sciences and Archives of Biochemistry and Biophysics.

In The Last Decade

Jing‐Ting Chiou

32 papers receiving 383 citations

Peers

Jing‐Ting Chiou
Laure Maneix United States
Jing‐Ting Chiou
Citations per year, relative to Jing‐Ting Chiou Jing‐Ting Chiou (= 1×) peers Laure Maneix

Countries citing papers authored by Jing‐Ting Chiou

Since Specialization
Citations

This map shows the geographic impact of Jing‐Ting Chiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing‐Ting Chiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing‐Ting Chiou more than expected).

Fields of papers citing papers by Jing‐Ting Chiou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing‐Ting Chiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing‐Ting Chiou. The network helps show where Jing‐Ting Chiou may publish in the future.

Co-authorship network of co-authors of Jing‐Ting Chiou

This figure shows the co-authorship network connecting the top 25 collaborators of Jing‐Ting Chiou. A scholar is included among the top collaborators of Jing‐Ting Chiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing‐Ting Chiou. Jing‐Ting Chiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiou, Jing‐Ting & Long‐Sen Chang. (2024). ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells. Biochemical Pharmacology. 224. 116242–116242. 2 indexed citations
2.
Chiou, Jing‐Ting & Long‐Sen Chang. (2023). Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression. APOPTOSIS. 29(3-4). 503–520. 4 indexed citations
3.
Chiou, Jing‐Ting, Yuan‐Chin Lee, & Long‐Sen Chang. (2023). Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition. Biochemical Pharmacology. 218. 115934–115934.
4.
Lee, Yuan‐Chin, Jing‐Ting Chiou, & Long‐Sen Chang. (2023). AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK/miR-22/HuR axis in chronic myeloid leukemia cells. Biochemical Pharmacology. 209. 115442–115442. 5 indexed citations
5.
Chiou, Jing‐Ting, Yuying Wu, Yuan‐Chin Lee, & Long‐Sen Chang. (2023). BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells. Biochemical Pharmacology. 215. 115738–115738. 8 indexed citations
6.
Chiou, Jing‐Ting, et al.. (2023). Cytarabine-induced destabilization of MCL1 mRNA and protein triggers apoptosis in leukemia cells. Biochemical Pharmacology. 211. 115494–115494. 7 indexed citations
7.
Chiou, Jing‐Ting, Yuan‐Chin Lee, Liangjun Wang, & Long‐Sen Chang. (2022). BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells. Chemico-Biological Interactions. 361. 109978–109978. 14 indexed citations
8.
Shi, Yijun, Jing‐Ting Chiou, Chia‐Hui Huang, et al.. (2022). Functional and structural properties of cardiotoxin isomers produced by blocking negatively charged groups. Archives of Biochemistry and Biophysics. 722. 109209–109209. 4 indexed citations
9.
Lee, Yuan‐Chin, Jing‐Ting Chiou, Liangjun Wang, & Long‐Sen Chang. (2022). Hydroquinone destabilizes BIM mRNA through upregulation of p62 in chronic myeloid leukemia cells. Biochemical Pharmacology. 199. 115017–115017. 4 indexed citations
10.
Wang, Liangjun, Yuan‐Chin Lee, Jing‐Ting Chiou, Ying‐Jung Chen, & Long‐Sen Chang. (2022). Effects of SIDT2 on the miR-25/NOX4/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF-α expression in hydroquinone-treated leukemia cells. Cell Biology and Toxicology. 39(5). 2207–2225. 9 indexed citations
11.
Chiou, Jing‐Ting, Liangjun Wang, Yuan‐Chin Lee, & Long‐Sen Chang. (2021). Naja atra Cardiotoxin 1 Induces the FasL/Fas Death Pathway in Human Leukemia Cells. Cells. 10(8). 2073–2073. 13 indexed citations
12.
Wang, Liangjun, Jing‐Ting Chiou, Yuan‐Chin Lee, & Long‐Sen Chang. (2021). Docetaxel-triggered SIDT2/NOX4/JNK/HuR signaling axis is associated with TNF-α-mediated apoptosis of cancer cells. Biochemical Pharmacology. 195. 114865–114865. 17 indexed citations
13.
Chiou, Jing‐Ting, Yuan‐Chin Lee, Chia‐Hui Huang, et al.. (2021). Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells. Biochemical Pharmacology. 188. 114544–114544. 10 indexed citations
14.
Chiou, Jing‐Ting, Chia‐Hui Huang, Liangjun Wang, et al.. (2021). CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells. Toxicology and Applied Pharmacology. 435. 115847–115847. 8 indexed citations
15.
Huang, Chia‐Hui, Yuan‐Chin Lee, Jing‐Ting Chiou, et al.. (2020). Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells. Toxicology and Applied Pharmacology. 397. 115013–115013. 18 indexed citations
16.
Lee, Yuan‐Chin, Liangjun Wang, Chia‐Hui Huang, et al.. (2020). Inhibition of EGFR pathway promotes the cytotoxicity of ABT-263 in human leukemia K562 cells by blocking MCL1 upregulation. Biochemical Pharmacology. 178. 114047–114047. 3 indexed citations
17.
Shi, Yijun, Chia‐Hui Huang, Yuan‐Chin Lee, et al.. (2020). Status of Asp29 and Asp40 in the Interaction of Naja atra Cardiotoxins with Lipid Bilayers. Toxins. 12(4). 262–262. 6 indexed citations
18.
Chiou, Jing‐Ting, Yuan‐Chin Lee, Chia‐Hui Huang, et al.. (2019). Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells. Toxicology and Applied Pharmacology. 387. 114857–114857. 13 indexed citations
19.
Shi, Yijun, Chia‐Hui Huang, Yuan‐Chin Lee, et al.. (2019). Naja atra cardiotoxins enhance the protease activity of chymotrypsin. International Journal of Biological Macromolecules. 136. 512–520. 11 indexed citations
20.
Uen, Wu‐Yih, et al.. (2003). Generation lifetime improvement on MOS capacitor by fast neutron enhanced intrinsic gettering technique. Microelectronics Journal. 34(2). 127–131. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026